ResearcherShanxi Medical UniversityActive in the last 2 years

Lijun Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9525-0090; OpenAlex author ID A5101754455. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-025-08177-9 ↗
IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis. Last author DOI 10.1111/bcpt.13694 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yingying Tong · 1 shared paper, 2025 · strength 0.22
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9 ↗
Li Wang · 1 shared paper, 2025 · strength 0.22
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9 ↗
Jing Wang · 1 shared paper, 2025 · strength 0.22
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9 ↗
yaoxian Xiang · 1 shared paper, 2025 · strength 0.22
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9 ↗
Dong Yan · 1 shared paper, 2025 · strength 0.22
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9 ↗
Yanbo Zheng · 1 shared paper, 2022 · strength 0.20
- Paper IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis. DOI 10.1111/bcpt.13694 ↗
Qi Zhao · 1 shared paper, 2022 · strength 0.20
- Paper IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis. DOI 10.1111/bcpt.13694 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.